Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Total 13F shares
-
135,271,135
-
Share change
-
-11,040,695
-
Total reported value
-
$413,881,848
-
Put/Call ratio
-
46%
-
Price per share
-
$3.06
-
Number of holders
-
198
-
Value change
-
-$32,445,335
-
Number of buys
-
86
-
Number of sells
-
87
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q3 2025
As of 30 Sep 2025,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
198 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,271,135 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, NORTHERN TRUST CORP, Divisadero Street Capital Management, LP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
198
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.